Prediction of Treatment Response to Chemoimmunotherapy

Prediction of treatment response to chemoimmunotherapy: concerted effort needed. Jun Hyeok Lim, MD. Jun Hyeok Lim, MD. Affiliations Division of Pulmonology.

Prediction of Treatment Response to Chemoimmunotherapy - PubMed

Prediction of Treatment Response to Chemoimmunotherapy: Concerted Effort Needed.

5 This result suggests that STK11, KEAP1, and KRAS mutation status have limited clinical utility as predictive biomarkers for patients with metastatic NSCLC ...

Study identifies biomarker that may predict treatment response to ...

They found that patients with elevated levels of CX3CR1 after six and nine weeks of treatment were more likely to see long-terms benefits from ...

Prediction of response to neoadjuvant chemo-immunotherapy in ...

Neoadjuvant chemo-immunotherapy combination has shown remarkable advances in the management of esophageal squamous cell carcinoma (ESCC).

Predicting treatment outcomes using 18F-FDG PET biomarkers in ...

Predictive markers for treatment response and survival outcome have not been identified in patients with advanced non-small-cell lung cancer (NSCLC) ...

(PDF) Prediction of Treatment Response to Chemoimmunotherapy

Prediction of Treatment Response to Chemoimmunotherapy: Concerted Effort Needed ; patients with NSCLC. Li et ; with better OS and PFS ; the basis ...

Non-invasive prediction for pathologic complete response ... - Frontiers

Neoadjuvant chemoimmunotherapy has revolutionized the therapeutic strategy for non-small cell lung cancer (NSCLC), and identifying candidates ...

Assessing treatment outcomes of chemoimmunotherapy in extensive

Mining whole- lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a ...

A convolutional attention model for predicting response to chemo ...

This study focuses on the prediction of tumor response to chemo-immunotherapy, exploring the potential of tumor mechanics and medical imaging as predictive ...

Predictors of Complete Pathological Response with ... - MDPI

Further studies are needed to identify additional possible biomarkers for predicting the response to neoadjuvant chemoimmunotherapy in TNBC patients, aiming to ...

Prediction of Treatment Response to Chemoimmunotherapy

Title. Prediction of Treatment Response to Chemoimmunotherapy: Concerted Effort Needed · Creator. Lim, Jun Hyeok · Is Part Of. Journal of thoracic oncology, 2023- ...

Deep learning for predicting major pathological response to ...

... response to neoadjuvant chemoimmunotherapy which serves as a promising treatment for NSCLC, remains uncertain. In addition, the previously ...

Cancer immunotherapy response prediction from multi-modal ...

Immunotherapy is a standard treatment for many tumor types. However, only a small proportion of patients derive clinical benefit and reliable predictive ...

Prediction of Treatment Response to Chemoimmunotherapy ... - OUCI

Prediction of Treatment Response to Chemoimmunotherapy: Concerted Effort Needed ... chemotherapy versus chemotherapy for metastatic NSCLC, JTO Clin Res Rep, № 4 ...

an integrated clinical and radiomics approach

No reliable biomarker is available so far to predict the treatment outcomes of chemoimmunotherapy in ES-SCLC. ... predict immunotherapy response.15 On the ...

Prediction of Response in Cancer Immunotherapy

This review focuses on the relationship between pre-treatment immune parameter values and outcome of immunotherapy of cancer patients. The evidence presented in ...

Prediction of pathologic complete response to ... - ASCO Publications

The cutoff value of ≥ 50% identified patients with a very high probability of pCR. The results reinforce TILs' use as a biomarker for treatment ...

Predictors of response to immunotherapy in colorectal cancer

Immunotherapy emerges as a promising avenue, albeit its efficacy is predominantly acknowledged in patients exhibiting microsatellite instability ...

Predicting pathological response to neoadjuvant or conversion ...

Chemoimmunotherapy-related pathological response prediction model (NACIP) was based on CT images from patients with stage IB–III NSCLC who ...